<DOC>
	<DOCNO>NCT02712801</DOCNO>
	<brief_summary>This multi-center , randomize , control , open clinical trial . The trial carry five province China . Pregnant woman HIV infection high risk mother-to-child transmission HIV identify . Their newborn baby high risk HIV infection recruit randomized intervention control group . Children intervention group receive ART intensive HIV test birth . Children control group receive routine prevention mother-to-child transmission service . All include child follow development infection status record compare .</brief_summary>
	<brief_title>Antiretroviral Regime Viral Eradication Newborns</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>child whose mother HIV infection child whose mother receive antiretroviral drug 36 gestational week receive drug delivery live birth birth weight less 2000g Apgar score less 3 1 minute birth less 6 5 minute birth .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Day</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>antiretroviral treatment</keyword>
	<keyword>child</keyword>
	<keyword>test</keyword>
</DOC>